Evidence map›Paper›PMID 38877304›Full record

ArticleThe EMBO journal2024

Spatially targeted chemokine exocytosis guides transmigration at lymphatic endothelial multicellular junctions.

Inam Liaqat, Ida Hilska, Maria Saario, Emma Jakobsson, Marko Crivaro, Johan Peränen, Kari Vaahtomeri

Abstract read
In one paragraph

Article in The EMBO journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inam LiaqatTranslational Cancer Medicine Research Program, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1308-6099
Ida HilskaTranslational Cancer Medicine Research Program, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0009-0005-3006-3998
Maria SaarioTranslational Cancer Medicine Research Program, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Emma JakobssonTranslational Cancer Medicine Research Program, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Marko CrivaroLight Microscopy Unit, Institute of Biotechnology, HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.
Johan PeränenInstitute of Biotechnology, HiLIFE, University of Helsinki, FI-00014, Helsinki, Finland.ORCID http://orcid.org/0000-0002-7807-3889
Kari VaahtomeriTranslational Cancer Medicine Research Program, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland. kari.vaahtomeri@helsinki.fi.ORCID http://orcid.org/0000-0001-7829-3518

Funding

Research Council of Finland (AKA) 315710Research Council of Finland (AKA) 356849
6 · The paper itself

Abstract

Migrating cells preferentially breach and integrate epithelial and endothelial monolayers at multicellular vertices. These sites are amenable to forces produced by the migrating cell and subsequent opening of the junctions. However, the cues that guide migrating cells to these entry portals, and eventually drive the transmigration process, are poorly understood. Here, we show that lymphatic endothelium multicellular junctions are the preferred sites of dendritic cell transmigration in both primary cell co-cultures and in mouse dermal explants. Dendritic cell guidance to multicellular junctions was dependent on the dendritic cell receptor CCR7, whose ligand, lymphatic endothelial chemokine CCL21, was exocytosed at multicellular junctions. Characterization of lymphatic endothelial secretory routes indicated Golgi-derived RAB6+ vesicles and RAB3+/27+ dense core secretory granules as intracellular CCL21 storage vesicles. Of these, RAB6+ vesicles trafficked CCL21 to the multicellular junctions, which were enriched with RAB6 docking factor ELKS (ERC1). Importantly, inhibition of RAB6 vesicle exocytosis attenuated dendritic cell transmigration. These data exemplify how spatially-restricted exocytosis of guidance cues helps to determine where dendritic cells transmigrate.

Indexed as

Chemokine CCL21Dendritic CellsExocytosisrab GTP-Binding ProteinsReceptors, CCR7AnimalsCell MovementCells, CulturedCoculture TechniquesEndothelial CellsEndothelium, LymphaticHumansIntercellular JunctionsMiceMice, Inbred C57BLTransendothelial and Transepithelial MigrationCcr7 protein, mouseChemokine CCL21Rab6 proteinrab GTP-Binding ProteinsReceptors, CCR7Chemokine CCL21Lymphatic EndotheliumMulticellular JunctionsTargeted ExocytosisTransmigration

Identifiers

PMID38877304
PMCPMC11294460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.